Drug Shortage Report for RAN-ROPINIROLE

Last updated on 2023-08-16 History
Report ID 158553
Drug Identification Number 02314037
Brand name RAN-ROPINIROLE
Common or Proper name ROPINIROLE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) ROPINIROLE
Strength(s) 0.25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N04BC
ATC description DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-07-06
Actual start date 2022-09-09
Estimated end date 2023-10-15
Actual end date
Shortage status Actual shortage
Updated date 2023-08-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2023-08-16 French Compare
v24 2023-08-16 English Compare
v23 2023-04-10 French Compare
v22 2023-04-10 English Compare
v21 2023-03-24 French Compare
v20 2023-03-24 English Compare
v19 2023-03-10 French Compare
v18 2023-03-10 English Compare
v17 2022-12-13 French Compare
v16 2022-12-13 English Compare
v15 2022-12-13 French Compare
v14 2022-12-13 English Compare
v13 2022-11-25 French Compare
v12 2022-11-25 English Compare
v11 2022-11-03 French Compare
v10 2022-11-03 English Compare
v9 2022-09-10 English Compare
v8 2022-08-25 French Compare
v7 2022-08-25 English Compare
v6 2022-08-19 French Compare

Showing 1 to 20 of 25